Skip to content
★ Sign in to follow
WP

William P. Murphy Jr.

Board Director
Director
U.S. Stem Cell, Inc.
Total declarations
51
Company
1
▲ Purchases (28 ops.)
€972k
▼ Sales (0 ops.)
—

Latest filing published 23 Jul 2021 for U.S. Stem Cell, Inc..

Filing timeline

BuySale
William P. Murphy Jr.

Insider track record

Disclosed buys
28
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
28
Positive at T+90
20%
Median T+90
-28.6%

Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 13 Nov 2015 · 4013 days ago · €1,301
    -99.7%
    Entry US$0.92 · Close at T+365 US$0.00
  • Filed 29 Oct 2015 · 4028 days ago · €434
    -99.5%
    Entry US$0.94 · Close at T+365 US$0.00
  • Filed 19 Oct 2015 · 4038 days ago · €1,258
    -99.7%
    Entry US$0.90 · Close at T+365 US$0.00
  • Filed 13 Oct 2015 · 4044 days ago · €806
    -99.8%
    Entry US$1.70 · Close at T+365 US$0.00
  • Filed 07 Oct 2015 · 4050 days ago · €248
    -99.7%
    Entry US$1.60 · Close at T+365 US$0.01

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

William P. Murphy Jr.: trading record in brief

William P. Murphy Jr. is a declared insider of U.S. Stem Cell, Inc. (board member), with filings sourced from SEC (Form 4). Between 1 July 2009 and 23 March 2021, the trades on record add up to 51 filings.

No open-market sale appears; the market trades are 28 purchases worth €972k. The totals do not cover 14 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 1 option exercise.

Half of the purchases are above €19k and half below. Ninety days after publication, 10 purchases show a median change of -28.6%, with the price up in 20% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 23 July 2021, the filings show a share grant in U.S. Stem Cell, Inc. The most recent open-market purchase was published on 25 August 2017, 3,362 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to William P. Murphy Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations49 total

25 of 49 declarations